Cite
HARVARD Citation
Moutafi, M. et al. (2022). Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Journal for immunotherapy of cancer. 10 (8), p. . [Online].